Capabilities · Lyophilization
Pioneers in Lyophilization
Mac-Chem's Boisar plant runs multiple lyophilizers, including 140 L and 400 L units, dedicated to Lyophilized Bulk Sterile API manufacturing, with containment built for cytotoxic compounds.
Lyophilized Bulk Sterile API · 15,000 kg/yr installed capacity
Why lyophilization
A dedicated segment: Lyophilized Bulk Sterile API
Lyophilized Bulk Sterile API is one of Mac-Chem's three API segments, alongside Oncology API and General API. It covers active pharmaceutical ingredients manufactured, freeze-dried, and released in sterile bulk form for formulation partners who require this dosage-form starting material. Mac-Chem markets its lyophilization work under the line "Pioneers in Lyophilization."
Installed equipment
Multiple lyophilizers, including 140 L and 400 L units
The Boisar plant operates multiple lyophilizers, including 140 L and 400 L units, dedicated to freeze-drying sterile bulk API. This equipment sits alongside the plant's 8 stainless-steel and 6 glass-lined reactors, and its steam and dry-heat sterilizers.
Containment
Cytotoxic handling under dedicated containment
Lyophilized Bulk Sterile API manufacturing, including cytotoxic oncology molecules, runs under Mac-Chem's Cat III & IV containment facility, with glove-box technology purpose-built for cytotoxic substances, and under fully automated, GAMP-compliant control.
Capacity
Installed annual capacity
Lyophilized Bulk Sterile API carries an installed annual capacity of 15,000 kg/yr, one of Mac-Chem's three API segments alongside Oncology API (15,000 kg/yr) and General API (10,000 kg/yr).
-
15,000 kg/yr
Lyophilized Bulk Sterile API
-
15,000 kg/yr
Oncology API
-
10,000 kg/yr
General API